Paper6252829
Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency.
Greenwood D and 3 others. Antimicrob Agents Chemother, 1980. Cited by 82 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency. Papers, record 6252829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6252829
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteria | Major topic |
| Cephalosporins | Major topic |
| Cefotaxime | |
| Ceftizoxime | |
| Chemical Phenomena | |
| Chemistry | |
| Culture Media | |
| Drug Resistance, Microbial | |
| Escherichia coli | |
| Humans | |
| Models, Biological | |
| Species Specificity | |
| Urinary Bladder |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,579,140 | Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4579140 | PubMed |
| 2 | 4,588,037 | A twelve channel bacterial growth monitoring system. | Biomed Eng | 1973 | https://conductscience.org/library/papers/4588037 | PubMed |
| 3 | 1,041,500 | Resistance categories of enterobacteria to beta-lactam antibiotics. | J Infect Dis | 1975 | https://conductscience.org/library/papers/1041500 | PubMed |
| 4 | 413,795 | Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study. | Infection | 1977 | https://conductscience.org/library/papers/413795 | PubMed |
| 5 | 348,666 | An in vitro model of the urinary bladder. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/348666 | PubMed |
| 6 | 308,505 | Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/308505 | PubMed |
| 7 | 308,506 | Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/308506 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,401,470 | The Chemical Relationship Among Beta-Lactam Antibiotics and Potential Impacts on Reactivity and Decomposition. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35401470 | PubMed |
| 32,687,523 | Stability of β-lactam antibiotics in bacterial growth media. | PLoS One | 2020 | https://conductscience.org/library/papers/32687523 | PubMed |
| 25,888,392 | Extended spectrum β-lactamase-producing Escherichia coli forms filaments as an initial response to cefotaxime treatment. | BMC Microbiol | 2015 | https://conductscience.org/library/papers/25888392 | PubMed |
| 11,286,322 | A retrospective analysis of pharmacokinetic-pharmacodynamic parameters as indicators of the clinical efficacy of ceftizoxime. | Clin Pharmacokinet | 2001 | https://conductscience.org/library/papers/11286322 | PubMed |
| 7,247,361 | Activity of a new cephalosporin antibiotic, Ro 13-9904 against dense populations of selected enterobacteria. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7247361 | PubMed |
| 7,114,839 | Comparative activities of 13 beta-lactam antibiotics. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/7114839 | PubMed |
| 6,407,392 | In vitro antimicrobial activity of eight new beta-lactam antibiotics against penicillin-resistant Neisseria gonorrhoeae. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6407392 | PubMed |
| 6,324,670 | Treatment of bacterial meningitis with ceftizoxime. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6324670 | PubMed |
| 6,323,320 | Ceftizoxime (FK 749) in vitro antibacterial activity. | Infection | 1984 | https://conductscience.org/library/papers/6323320 | PubMed |
| 6,322,676 | Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6322676 | PubMed |
| 6,314,887 | Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6314887 | PubMed |
| 6,295,270 | Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6295270 | PubMed |
| 6,284,649 | Elimination of bacteria in biliary tract infections during ceftizoxime therapy. | Infection | 1982 | https://conductscience.org/library/papers/6284649 | PubMed |
| 6,272,629 | In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6272629 | PubMed |
| 6,100,425 | Elimination kinetics of ceftizoxime in humans with and without renal insufficiency. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6100425 | PubMed |
| 3,888,599 | Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. | Drugs | 1985 | https://conductscience.org/library/papers/3888599 | PubMed |
| 3,466,569 | Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3466569 | PubMed |
| 3,319,505 | In vitro antibacterial effects of cephalosporins. | Drugs | 1987 | https://conductscience.org/library/papers/3319505 | PubMed |
| 2,327,757 | Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2327757 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6252829
GET https://conductscience.org/api/papers/v1/6252829/authors